# US 8,278,455 B2 · 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,455 B2
- Document ID: US8278455B2
- Status: Granted
- Kind: B2
- Application number: 12/253,450
- Filed: 2008-10-17
- Published: 2009-03-05
- Granted: 2012-10-02
- Earliest claimed: 2003-12-18
- Assignees: Janssen Pharmaceutica NV
- Inventors: Jean-François Bonfanti; Koenraad Jozef Lodewijk Andries; Jérôme Michel Claude Fortin; Philippe Muller; Frédéric Marc Maurice Doublet; Christophe Meyer; Rudy Edmond Willebrords; Tom Valerius Josepha Gevers; Philip Maria Martha Bern Timmerman
- Web page: https://patentgrep.com/patent/US8278455B2

## CPC

- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/12: Antivirals
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 401/14: containing three or more hetero rings
- C07D 405/14: containing three or more hetero rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention concerns 5- or 6-substituted-benzimidazole derivatives having inhibitory activity on the replication of the respiratory syncytial virus and having the formula a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein Q is Ar2, R6, pyrrolidinyl substituted with R6, piperidinyl substituted with R6 or homopiperidinyl substituted with R6, G is a direct bond or optionally substituted C1-10alkanediyl; R1 is Ar1 or a monocyclic or bicyclic heterocycle; one of R2a and R2b is cyanoC1-6alkyl, cyanoC2-6alkenyl, Ar3C1-6alkyl, Het1C1-6alkyl, N(R8aR8b)C1-6alkyl, Ar3C2-6alkenyl, Het1C2-6alkenyl, Ar3aminoC1-6alkyl, Het1aminoC1-6alkyl, Ar3thioC1-6alkyl, Het1thioC1-6alkyl, Ar3sulfonylC1-6alkyl, Het1sulfonylC1-6alkyl, Ar3aminocarbonyl, Het1aminocarbonyl, Ar3(CH2)namino-carbonyl, Het1(CH2)naminocarbonyl, Ar3carbonylamino, Het1carbonylamino, Ar3(CH2)ncarbonylamino, Het1(CH2)ncarbonylamino, and the other one of R2a and R2b is hydrogen; in case R2a is hydrogen, then R3 is hydrogen; in case R2b is hydrogen, the R3 is hydrogen or C1-6alkyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.

## Claims

### Claim 1

A compound of the formula
a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein
R is C1-6alkyl substituted with one or with two substituents each independently selected from the group consisting of trifluoromethyl, NR7aR7b, Ar2, hydroxy, C1-4alkoxy, Ar2(CH2)noxy, hydroxycarbonyl, aminocarbonyl, C1-4alkylcarbonyl, C1-4alkoxycarbonyl, Ar2(CH2)ncarbonyl, aminocarbonyloxy, C1-4alkylcarbonyloxy, Ar2carbonyloxy, mono- or di(C1-4alkyl)aminocarbonyl, aminosulfonyl, mono- or di(C1-4alkyl)aminosulfonyl and a heterocycle selected from the group consisting of pyrrolidinyl, imidazolyl, piperidinyl, homopiperidinyl, piperazinyl, dioxolanyl, dioxanyl, di-C1-6alkyl-dioxolanyl and pyridyl, wherein each of said heterocycle may optionally be substituted with with one or two radicals selected from oxo and C1-6alkyl;
R7a is hydrogen, C1-6alkyl, formyl or C1-6alkylcarbonyl;
R7b is hydrogen, C1-6alkyl, formyl or C1-6alkylcarbonyl;
one of R2a and R2b is cyanoC1-6alkyl, cyanoC2-6alkenyl, Ar3C1-6alkyl, (Ar3)(OH)C1-6alkyl, Het-C1-6alkyl, N(R8aR8b)C1-6alkyl, Ar3C2-6alkenyl, Het-C2-6alkenyl, Ar3aminoC1-6alkyl, Het-aminoC1-6alkyl, Het-C1-6alkylaminoC1-6alkyl, Ar3thioC1-6alkyl, Het-thioC1-6alkyl, Ar3sulfonylC1-6alkyl, Het-sulfonylC1-6alkyl, Ar3aminocarbonyl, Het-aminocarbonyl, Ar3(CH2)naminocarbonyl, Het-(CH2)naminocarbonyl, Ar3carbonylamino, Het-carbonylamino, Ar3(CH2)ncarbonylamino, Het-(CH2)ncarbonylamino, or Ar3(CH2)namino; and the other one of R2a and R2b is hydrogen;
R8a is Ar3, C1-6alkyl, hydroxyC1-6alkyl, C1-6alkoxyC1-6alkyl, cyanoC1-6alkyl, aminoC1-6alkyl, mono-or di(C1-6alkyl)aminoC1-6alkyl, Ar3C1-6alkyl, Het-C1-6alkyl, aminocarbonyl-C1-6-alkyl, hydrogen, or carboxyl-C1-6-alkyl;
R8b is Ar3, C1-6alkyl, hydroxyC1-6alkyl, C1-6alkoxyC1-6alkyl, cyanoC1-6alkyl, aminoC1-6alkyl, mono-or di(C1-6alkyl)aminoC1-6alkyl, Ar3C1-6alkyl, hydrogen, or Het-C1-6alkyl;
Ar3 is phenyl, naphthalenyl, 1,2,3,4-tetrahydro-naphthalenyl or indanyl, wherein said phenyl, naphtyl, 1,2,3,4-tetrahydro-naphthalenyl or indanyl may optionally and each individually be substituted with 1 to 4 substituents selected from the group consisting of halo, hydroxy, mercapto, amino, cyano, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, Ar1, hydroxyC1-6alkyl, polyhaloC1-6alkyl, aminoC1-6alkyl, cyanoC1-6alkyl, aminocarbonyl, C1-6alkyloxy, C1-6alkylthio, Ar1-oxy, Ar1-thio, Ar1-amino, aminosulfonyl, aminocarbonyl-C1-6alkyl, hydroxycarbonyl-C1-6alkyl, hydroxycarbonyl, C1-4alkylcarbonyl, mono- or di(C1-4alkyl)amino, mono- or di(C1-4alkyl)aminocarbonyl, mono- or di(C1-4alkyl)aminosulfonyl, mono- or di(C1-4alkyl)aminoC 1-6alkyl, C1-4alkylcarbonylamino and C1-4alkoxycarbonyl;
Ar1 is phenyl or phenyl substituted with 1 to 4 substituents selected from the group consisting of halo, hydroxy, C1-6alkyl, hydroxyC1-6alkyl, polyhaloC 1-6alkyl, and C 1-6alkyloxy;
Ar2 is phenyl or phenyl substituted with 1 to 4 substituents selected from the group consisting of halo, hydroxy, amino, cyano, C 1-6alkyl, hydroxyC1-6alkyl, polyhaloC1-6alkyl, aminoC1-6alkyl, C1-6alkyloxy, aminosulfonyl, aminocarbonyl, hydroxycarbonyl, C1-4alkylcarbonyl, mono- or di(C1-4alkyl)amino, mono- or di(C1-4alkyl)aminocarbonyl, mono- or di(C1-4alkyl)aminosulfonyl, mono- or di(C1-4alkyl)aminoC1-6alkyl and C1-4alkoxycarbonyl; and
Het is a heterocycle selected from the group consisting of tetrahydrofuranyl, tetrahydrothienyl, dioxanyl, dioxolanyl, pyrrolidinyl, pyrrolidinonyl, furanyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, piperidinyl, homopiperidinyl, piperazinyl, morpholinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, tetrahydroquinolinyl, quinolinyl, isoquinolinyl, benzodioxanyl, benzodioxolyl, indolinyl, and indolyl; each of said heterocycles may optionally be substituted with oxo, amino, Ar1, C1-4alkyl, aminoC1-4alkyl, hydroxyC1-6alkyl, Ar1C1-4alkyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, mono- or di(C1-6alkyl)amino, or with two C1-4alkyl radicals.

### Claim 2 (depends on 1)

A compound according to claim 1, wherein one of R2a and R2b is selected from cyanoC1-6alkyl, cyano C2-6alkenyl, Ar3C1-6alkyl, (Ar3)(OH) C1-6alkyl, Het- C1-6alkyl, N(R8aR8b) C1-6alkyl, Ar3C2-6alkenyl, Het-C2-6alkenyl, Ar3aminoC1-6alkyl, Het-amino C1-6alkyl, Het-C1-6alkylaminoC1-6alkyl, Ar3thioC1-6alkyl, Het-thioC1-6alkyl, Ar3sulfonylC1-6alkyl, Het-sulfonylC1-6alkyl, Ar3aminocarbonyl, Het-aminocarbonyl, Ar3(CH2)naminocarbonyl, Het-(CH2)naminocarbonyl, Ar3carbonylamino, or Ar3(CH2)namino; and the other one of R2a and R2b is hydrogen.

### Claim 3 (depends on 1)

A compound according to claim 1, wherein one of R2a and R2b is selected from cyanoC1-6alkyl, Ar3C1-6alkyl, Het-C1-6alkyl, N(R8aR8b)C1-6alkyl, Ar3C2-6alkenyl, Ar3aminoC1-6alkyl, Het-aminoC1-6alkyl, Het-C1-6alkylaminoC1-6alkyl, Ar3thioC1-6alkyl, Ar3aminocarbonyl, Het-aminocarbonyl, Ar3(CH2)naminocarbonyl, or Het-(CH2)naminocarbonyl; and the other one of R2a and R2b is hydrogen.

### Claim 4 (depends on 1)

A compound according to claim 1, wherein one of R2a and R2b is selected from N(R8aR8b)C1-6alkyl, or Ar3aminoC1-6alkyl; and the other one of R2a and R2b is hydrogen.

### Claim 5 (depends on 1)

A compound according to claim 1, wherein R is C1-6alkyl substituted with Ar2 or hydroxyl, or C1-6alkyl substituted with two 5ydroxyl radicals, or C1-6alkyl substituted with di-C1-6alkyl-dioxolanyl, pyrrolidinyl, piperidinyl, piperazinyl, or 4-C1-6alkyl-piperazinyl.

### Claim 6 (depends on 1)

A compound according to claim 1, wherein R8a is Ar3, C1-6alkyl, hydroxyC1-6alkyl, C1-6alkoxyC1-6alkyl, cyanoC1-6alkyl, amino C1-6alkyl, mono-or di(C1-6alkyl)aminoC1-6alkyl, Ar3C1-6alkyl, Het-C1-6alkyl, amino carbonyl-C1-6alkyl, or carboxyl-C1-6-alkyl; and R8b is Ar3.

### Claim 7 (depends on 1)

A compound according to claim 1, wherein R8a is C1-6alkyl, hydroxyC1-6alkyl, Ar3C1-6alkyl, Het-C1-6alkyl, or aminocarbonyl-C1-6-alkyl; and R8b is C1-6alkyl, hydroxyC1-6alkyl, Ar3C1-6alkyl, or Het-C1-6alkyl.

### Claim 8 (depends on 1)

A compound according to claim 1, wherein Ar3 is phenyl optionally substituted with one, two or three substituents selected from halo, hydroxyl, mercapto, amino, cyano, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, Ar1, hydroxyC1-6alkyl, CF3, aminoC1-6alkyl, cyanoC1-6alkyl, aminocarbonyl, C1-6alkyloxy, C1-6alkylthio, Ar1-oxy, Ar1-thio, Ar1-amino, aminosulfonyl, aminocarbonyl-C1-6alkyl, hydroxycarbonyl-C1-6alkyl, hydroxycarbonyl, C1-4alkylcarbonyl, C1-4alkylcarbonylamino or C1-4alkoxycarbonyl.

### Claim 9 (depends on 8)

A compound according to claim 8, wherein Ar3 is phenyl substituted with one, two or three substituents selected from halo, C1-6alkyl or hydroxyC1-6alkyl.

### Claim 10 (depends on 8)

A compound according to claim 8, wherein Ar3 is phenyl substituted with two substituents which are methyl and hydroxyl.

### Claim 11 (depends on 10)

A compound according to claim 10, in which the R, R2a and R2b substituents are as follows:
R
R2b
R2a
H
H
H
H
H
H
H
H
H
H
H or
H

### Claim 12 (depends on 1)

A pharmaceutical composition comprising a pharmaceutically acceptable carrier, and as active ingredient a therapeutically effective amount of a compound as claimed in claim 1.
